|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,121.00 JPY | -0.98% |
|
-1.44% | +1.34% |
| 02:59am | Pfizer, Astellas Secure FDA Nod For Bladder Cancer Drug | MT |
| 07-10 | Health Care Down on Rotation Back to Tech - Health Care Roundup | DJ |
| Market Cap | 3,800B 23.41B 20.53B 19.02B 17.5B 33.1B 2,241B 33.74B 227B 88.89B 1,100B 87.9B 85.98B | P/E 2027 * |
11.1x | P/E 2028 * | 11.6x |
|---|---|---|---|---|---|
| Enterprise Value | 3,723B 22.94B 20.12B 18.63B 17.14B 32.43B 2,195B 33.06B 222B 87.1B 1,078B 86.13B 84.24B | EV / Sales 2027 * |
1.65x | EV / Sales 2028 * | 1.64x |
| Free-Float |
97.66% | Yield 2027 * |
3.79% | Yield 2028 * | 3.91% |
Last Transcript: Astellas Pharma Inc.
| 1 day | -0.98% | ||
| 1 week | -1.44% | ||
| Current month | -2.48% | ||
| 1 month | -0.89% | ||
| 3 months | -18.64% | ||
| 6 months | -5.16% | ||
| Current year | +1.34% |
| 1 week | 2,109 |  | 2,200 |
| 1 month | 2,105 | | 2,216.5 |
| Current year | 2,041 | | 2,717 |
| 1 year | 1,412.5 | | 2,717 |
| 3 years | 1,243.5 | | 2,717 |
| 5 years | 1,243.5 | | 2,717 |
| 10 years | 1,243.5 | | 2,717 |
| Manager | Title | Age | Since |
|---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 63 | 09/02/2023 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 54 | 31/10/2023 |
Tatjana Dragovic
CMP | Compliance Officer | - | 31/03/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenji Yasukawa
CHM | Chairman | 66 | 09/02/2023 |
Naoki Okamura
BRD | Director/Board Member | 63 | 31/05/2019 |
| Director/Board Member | 58 | 31/05/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.98% | -1.44% | +50.80% | +4.90% | 23.76B | |
| -0.56% | -1.52% | +47.86% | +171.88% | 1,060B | |
| +0.31% | -0.60% | +64.37% | +62.31% | 619B | |
| -0.03% | -2.65% | +29.49% | +85.64% | 438B | |
| -1.75% | -0.33% | +28.33% | +23.58% | 333B | |
| +0.24% | -0.42% | +29.19% | +47.26% | 282B | |
| -1.75% | -10.57% | +18.27% | +22.07% | 267B | |
| +0.67% | +1.03% | -26.81% | -37.96% | 218B | |
| -0.81% | -1.63% | +21.35% | +58.33% | 196B | |
| +1.21% | +1.38% | +17.23% | +71.29% | 161B | |
| Average | -0.51% | -3.05% | +28.01% | +50.93% | 359.77B | |
| Weighted average by Cap. | -0.45% | -3.08% | +35.67% | +83.41% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2,255B 13.89B 12.19B 11.29B 10.39B 19.64B 1,330B 20.03B 135B 52.76B 653B 52.17B 51.03B | 2,072B 12.77B 11.2B 10.37B 9.54B 18.05B 1,222B 18.4B 124B 48.48B 600B 47.94B 46.89B |
| Net income | 343B 2.11B 1.85B 1.72B 1.58B 2.99B 202B 3.05B 20.46B 8.03B 99.34B 7.94B 7.76B | 327B 2.02B 1.77B 1.64B 1.51B 2.85B 193B 2.91B 19.52B 7.65B 94.74B 7.57B 7.4B |
| Net Debt | -76.78B -473M -415M -384M -354M -669M -45.27B -682M -4.58B -1.8B -22.23B -1.78B -1.74B | -391B -2.41B -2.11B -1.96B -1.8B -3.41B -231B -3.47B -23.34B -9.15B -113B -9.05B -8.85B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/07/26 | JP¥2,121.00 | -0.98% | 4,304,400 |
| 10/07/26 | JP¥2,142.00 | +0.21% | 5,971,100 |
| 09/07/26 | JP¥2,137.50 | -0.42% | 4,773,500 |
| 08/07/26 | JP¥2,146.50 | -1.29% | 6,198,900 |
| 07/07/26 | JP¥2,174.50 | -1.52% | 6,880,100 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
